Skip to main content

Remote Job Finders (RJF)

The Job Market May Be Warming—What Does That Mean for You?

Employees are reassessing, leaders are celebrating data that should make them nervous and job seekers are absorbing a narrative that doesn’t match their reality. Executive coach Angela Justice discusses how each of these groups are affected when the job market thaws.

After Exiting 2seventy, Chip Baird Took a 180 to Food Allergy With Newly Launched Poplar

Poplar Therapeutics is seeking a “step change” in the treatment of food allergy and other atopic conditions, with $95 million raised to date, including a $45 million series A extension that closed Tuesday.

Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data

OSE Immunotherapeutics has kicked off a strategic realignment initiative that involves deprioritizing the AbbVie-partnered OSE-230 and focusing its resources on the late-stage development of its ulcerative colitis candidate lusvertikimab.

How North Carolina Attracted Amgen and Roche To Become a Next-Gen Obesity Drug Production Hotspot

Infrastructure and location have helped make Holly Springs a future hub for obesity drug production, with Amgen and Roche planning to manufacture GLP-1 therapies there to compete in the growing market.
Scroll to top